{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:59:14Z","timestamp":1765040354930},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":6931,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001]]},"DOI":"10.1093\/annonc\/12.suppl_1.s95","type":"journal-article","created":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T05:04:11Z","timestamp":1327035851000},"page":"S95-S96","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Trastuzumab in the treatment of advanced breast cancer: Single-center experience"],"prefix":"10.1016","volume":"12","author":[{"given":"M.","family":"Mrsi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grgi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Budi\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Podolski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bogdani\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Labar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jaki\u0107-Razumovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Restek-Samar\u017eija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Go\u0161ev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/12.suppl_1.S95_bb0010","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.1996.14.8.2197","article-title":"Long-term followup of patients with complete remission following combination chemotherapy for metastatic breast cancer","volume":"14","author":"Greenberg","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/12.suppl_1.S95_bb0015","first-page":"526","article-title":"Integration of new therapies into management of metastatic breast cancer: A focus on chemotherapy, treatment selection through use of molecular markers, and newly developed biologic therapies in late clinical development","author":"Piccart","year":"1999","journal-title":"Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/12.suppl_1.S95_bb0020","first-page":"1","article-title":"Current management of metastatic breast cancer","volume":"26","author":"Perez","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/12.suppl_1.S95_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1634\/theoncologist.4-1-17","article-title":"Monotherapy of metastatic breast cancer: A review of newer agents","volume":"4","author":"Vogel","year":"1999","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/12.suppl_1.S95_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: Correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1093\/annonc\/12.suppl_1.S95_bb0035","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.1999.17.9.2639","article-title":"Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease","volume":"17","author":"Cobleigh","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/12.suppl_1.S95_bb0040","first-page":"127a","article-title":"Overall survival (OS) advantage to Herceptin (H) in HER2-overexpressing (HER2+) metastatic breast cancer (MBC)","volume":"18","author":"Norton","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/12.suppl_1.S95_bb0045","first-page":"98a","article-title":"Addition of Herceptin\u00ae (humanized anti-HER2 antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer (HER2+\/MBC) markedly increases anticancer activity: A randomized multinational controlled phase III trial","volume":"17","author":"Slamon","year":"1998","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419544660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419544660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/suppl_1\/S95\/6672917\/12-suppl_1-S95.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:12:08Z","timestamp":1582182728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419544660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"references-count":8,"alternative-id":["S0923753419544660"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/12.suppl_1.s95","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001]]}}}